1. Sabapathy S, Maruthu S, Krishnadhas SK, Tamilarasan AK, Raghavan N. Competent and affordable rehabilitation robots for nervous system disorders powered with dynamic CNN and HMM. Intelligent systems for rehabilitation engineering, Wiley, 2022; 57-93.
2. Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) and its active constituents on nervous system disorders: A review. Iran J Basic Med Sci 2023; 26:2-12.
3. Hosseini M, Pkan P, Rakhshandeh H, Aghaie A, Sadeghnia HR, Rahbardar MG. The effect of hydro-alcoholic extract of citrus flower on pentylenetetrazole and maximal electroshock-induced seizures in mice. World Appl Sci J 2011; 15:1104-1109.
4. Tandisehpanah Z, Foroutanfar A, Aziminia A, Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Protective effect of aqueous and ethanolic extracts of Lippia citriodora Kunth. on acrylamide-induced neurotoxicity. Avicenna J Phytomed 2022; 12:281-294.
5. Ghobakhlou F, Eisvand F, Razavi BM, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Evaluating the effect of alpha-mangostin on neural toxicity induced by acrylamide in rats. Environ Sci Pollut Res Int 2023; 30:95789-95800.
6. Zhao J, Li Z, Zhang R, Yu H, Zhang L. Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease. BMC Complement Med Ther 2025; 25:94-111.
7. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. Iran J Basic Med Sci 2020; 23:1100-1112.
8. Nakisa N, Ghasemzadeh Rahbardar M. Therapeutic potential of rosemary (Rosmarinus officinalis L.) on sports injuries: A review of patents. Res J Pharmacogn 2022; 9:71-83.
9. Rahbardar MG, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine 2018; 40:59-67.
10. Ghasemzadeh Rahbardar M, Hemadeh B, Razavi BM, Eisvand F, Hosseinzadeh H. Effect of carnosic acid on acrylamide induced neurotoxicity: In vivo and in vitro experiments. Drug Chem Toxicol 2022; 45:1528-1535.
11. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effects of rosmarinic acid on nervous system disorders: an updated review. Naunyn Schmiedebergs Arch Pharmacol 2020; 393:1779-1795.
12. Ghasemzadeh MR, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. J Ethnopharmacol 2016; 194:117-130.
13. Ghasemzadeh Rahbardar M, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomed Pharmacother 2017; 86:441-449.
14. Alavi MS, Fanoudi S, Ghasemzadeh Rahbardar M, Mehri S, Hosseinzadeh H. An updated review of protective effects of rosemary and its active constituents against natural and chemical toxicities. Phytother Res 2021; 35:1313-1328.
15. Jalali J, Ghasemzadeh Rahbardar M. Rosemary: A promising therapeutic agent in alleviating nephrotoxicity. J Food Biochem 2025; 2025:5519628.
16. Naraki GA, Fazeli Kakhki H, Qoorchi Moheb Seraj F, Naraki K, Ghasemzadeh Rahbardar M. Effect of Crocus sativus L. (saffron) and Rosmarinus officinalis L. (rosemary) in hepatocellular carcinoma: A narrative review of current evidence and prospects. Iran J Basic Med Sci 2025; 28:986-1003.
17. Rahbardar MG, Eisvand F, Rameshrad M, Razavi BM, Hosseinzadeh H. In vivo and in vitro protective effects of rosmarinic acid against doxorubicin-induced cardiotoxicity. Nutr Cancer 2022; 74:747-760.
18. Ghasemzadeh Rahbardar M, Eisvand F, Rameshrad M, Razavi BM, Tabatabaee Yazdi A, Hosseinzadeh H. Carnosic acid mitigates doxorubicin-induced cardiac toxicity: Evidence from animal and cell model investigations. Iran J Basic Med Sci 2024; 27:425-438.
19. Nakisa N, Rahbardar MG. Action mechanisms of antirheumatic herbal medicines. Rheumatoid arthritis 2022; doi: 10.5772/intechopen.99133.
20. Rahbardar MG, Hosseinzadeh H. Mechanisms of action of herbal antidepressants. In: Martin CR, Hunter L-A, Patel VB, Preedy VR, Rajendram R, editors. The Neuroscience of Depression: Academic Press; 2021. p. 503-518.
21. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Therapeutic potential of hypnotic herbal medicines: A comprehensive review. Phytother Res 2024; 38:3037-3059.
22. Ghasemzadeh Rahbardar M, Boskabady MH. Herbal medicine approach to relieving dyspnea: A narrative review of efficacy and mechanisms. Iran J Basic Med Sci 2025; 28:1140-1162.
23. Ghasemzadeh Rahbardar M, Ferns GA, Ghayour Mobarhan M. Assessing the efficacy of herbal supplements for managing obesity: A comprehensive review of global clinical trials. Iran J Basic Med Sci 2025; 28:691-709.
24. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Toxicity and safety of rosemary (Rosmarinus officinalis): A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2025; 398:9-23.
25. Sharma Y, Fagan J, Schaefer J. In vitro screening for acetylcholinesterase inhibition and antioxidant potential in different extracts of sage (Salvia officinalis L.) and rosemary (Rosmarinus officinalis L.). J Biol Act Prod Nat 2020; 10:59-69.
26. Shalabalija D, Mihailova L, Crcarevska MS, Karanfilova IC, Ivanovski V, Nestorovska AK, et al. Formulation and optimization of bioinspired rosemary extract loaded PEGylated nanoliposomes for potential treatment of Alzheimer’s disease using design of experiments. J Drug Deliv Sci Technol 2021; 63:102434.
27. Kamli MR, Sharaf AAM, Sabir JSM, Rather IA. Phytochemical screening of Rosmarinus officinalis L. as a potential anticholinesterase and antioxidant-medicinal plant for cognitive decline disorders. Plants 2022; 11:514-528.
28. Zhao J, Li Z, Zhang R, Yu H, Zhang L. Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease. BMC Complement Med Ther 2025; 25:94-111.
29. Köksal Z, Şenol H. Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: A comprehensive in vitro and in silico study. Arch Pharm 2025; 358:e2400909.
30. Yi-Bin W, Xiang L, Bing Y, Qi Z, Fei-Tong J, Minghong W, et al. Inhibition of the CEBPβ-NFκB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer’s disease model. Cell Death Dis 2022; 13:318-335.
31. Liu WY, Li Y, Li Y, Xu LZ, Jia JP. Carnosic acid attenuates AβOs-induced apoptosis and synaptic impairment via regulating NMDAR2B and its downstream cascades in SH-SY5Y cells. Mol Neurobiol 2023; 60:133-144.
32. Kola A, Hecel A, Lamponi S, Valensin D. Novel perspective on Alzheimer’s disease treatment: Rosmarinic acid molecular interplay with copper(II) and amyloid β. Life 2020; 10:118-135.
33. Liu DY, Wu Y, Feng ZQ, Yu Y, Cai HW, Liao SP, et al. Rosmarinic acid against cognitive impairment via RACK1/HIF-1α regulated microglial polarization in sepsis-surviving mice. Chem Biol Interact 2024; 388:110830.
34. Li Q, Zheng JW, Wang ZY, Liao SP, Zhu L, Wang X, et al. Protective effect of rosmarinic acid on endotoxin-induced neuronal damage through modulating GRP78/PERK/MANF pathway. Drug Des Devel Ther 2025; 19:39-50.
35. Kaushik A, Kaura S, Mor R. Synthesis and characterization of pullulan encapsulated ursolic acid nanoparticles for enhanced bioavailability and acetylcholinesterase inhibition in Alzheimer’s disease therapy. International Journal of Pharmacy Research & Technology (IJPRT) 2025; 15:124-139.
36. Mirza FJ, Amber S, Sumera, Hassan D, Ahmed T, Zahid S. Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an Aβ(1-42)-induced mouse model of Alzheimer’s disease. Phytomedicine 2021; 83:153490.
37. Malik N, Amber S, Zahid S. Rosmarinus officinalis and methylphenidate exposure improves cognition and depression and regulates anxiety-like behavior in AlCl(3)-induced mouse model of Alzheimer’s disease. Front Pharmacol 2022; 13:943163.
38. Al-Tawarah NM, Al-Dmour RH, Abu Hajleh MN, Khleifat KM, Alqaraleh M, Al-Saraireh YM, et al. Rosmarinus officinalis and Mentha piperita oils supplementation enhances memory in a rat model of scopolamine-induced Alzheimer’s disease-like condition. Nutrients 2023; 15:1547-1567.
39. Sasaki K, Becker J, Ong J, Ciaghi S, Guldin LS, Savastano S, et al. Rosemary extract activates oligodendrogenesis genes in mouse brain and improves learning and memory ability. Biomed Pharmacother 2024; 179:117350.
40. Eslami Farsani M, Razavi S, Rasoolijazi H, Esfandiary E, Seyedebrahimi R, Ababzadeh S. Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats. Iran J Basic Med Sci 2024; 27:518-523.
41. Chen Y, Wang Y, Qin Q, Zhang Y, Xie L, Xiao J, et al. Carnosic acid ameliorated Aβ-mediated (amyloid-β peptide) toxicity, cholinergic dysfunction and mitochondrial defect in Caenorhabditis elegans of Alzheimer’s Model. Food Funct 2022; 13:4624-4640.
42. Banerjee P, Wang Y, Carnevale LN, Patel P, Raspur CK, Tran N, et al. diAcCA, a pro-drug for carnosic acid that activates the Nrf2 transcriptional pathway, shows efficacy in the 5xFAD transgenic mouse model of Alzheimer’s disease. Antioxidants 2025; 14:293-311.
43. Fachel FNS, Michels LR, Azambuja JH, Lenz GS, Gelsleichter NE, Endres M, et al. Chitosan-coated rosmarinic acid nanoemulsion nasal administration protects against LPS-induced memory deficit, neuroinflammation, and oxidative stress in Wistar rats. Neurochem Int 2020; 141:104875.
44. Li M, Cui MM, Kenechukwu NA, Gu YW, Chen YL, Zhong SJ, et al. Rosmarinic acid ameliorates hypoxia/ischemia induced cognitive deficits and promotes remyelination. Neural Regen Res 2020; 15:894-902.
45. Hassanzadeh-Taheri M, Ahmadi-Zohan A, Mohammadifard M, Hosseini M. Rosmarinic acid attenuates lipopolysaccharide-induced neuroinflammation and cognitive impairment in rats. J Chem Neuroanat 2021; 117:102008.
46. Thingore C, Kshirsagar V, Juvekar A. Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using rosmarinic acid in mice. Metab Brain Dis 2021; 36:299-313.
47. Yamamoto S, Kayama T, Noguchi-Shinohara M, Hamaguchi T, Yamada M, Abe K, et al. Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway. NPJ Sci Food 2021; 5:1-11.
48. Mirza FJ, Zahid S. Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer’s disease. Front Pharmacol 2022; 13:1058358.
49. Musillo C, Giona L, Ristow M, Zarse K, Siems K, Di Francesco A, et al. Rosmarinic acid improves cognitive abilities and glucose metabolism in aged C57Bl/6N mice while disrupting lipid profile in young adults in a sex-dependent fashion. Nutrients 2023; 15:3366-3380.
50. Yang M, Zhang X, Qiao O, Ji H, Zhang Y, Han X, et al. Rosmarinic acid potentiates and detoxifies tacrine in combination for Alzheimer’s disease. Phytomedicine 2023; 109:154600.
51. Giona L, Musillo C, De Cristofaro G, Ristow M, Zarse K, Siems K, et al. Western diet-induced cognitive and metabolic dysfunctions in aged mice are prevented by rosmarinic acid in a sex-dependent fashion. Clin Nutr 2024; 43:2236-2248.
52. Wang N, Wang E, Wang R, Muhammad F, Li T, Yue J, et al. Ursolic acid ameliorates amyloid β-induced pathological symptoms in Caenorhabditis elegans by activating the proteasome. Neurotoxicology 2022; 88:231-240.
53. Alizade S, Faramarzi M, Banitalebi E, Saghaei E. Effect of resistance and endurance training with ursolic acid on oxidative stress and cognitive impairment in hippocampal tissue in HFD/STZ-induced aged diabetic rats. Iran J Basic Med Sci 2023; 26:1449-1459.
54. Ghadiri N, Gorgin Karaji Z, Farsani ZH, Akbarzadeh H. The combined effects of resistance and endurance training with ursolic acid supplementation on some Alzheimer’s disease-related biomarkers in a rat model of type 2 diabetes. Bull Natl Res Cent 2024; 48:85-96.
55. Fatemeh D, Mitra M, Homa A, Somayyeh K-M. Antioxidant and anticholinergic effects of rosemary (Salvia rosmarinus) extract: A double-blind randomized controlled trial. Adv Integr Med 2022; 9:69-74.
56. Capatina L, Boiangiu RS, Dumitru G, Napoli EM, Ruberto G, Hritcu L, et al. Rosmarinus officinalis essential oil improves scopolamine-induced neurobehavioral changes via restoration of cholinergic function and brain antioxidant status in zebrafish (Danio rerio). Antioxidants 2020; 9:62-75.
57. Sasaki K, Ferdousi F, Fukumitsu S, Kuwata H, Isoda H. Antidepressant- and anxiolytic-like activities of Rosmarinus officinalis extract in rodent models: Involvement of oxytocinergic system. Biomed Pharmacother 2021; 144:112291.
58. Vilmosh N, Delev D, Kostadinov I, Zlatanova H, Kotetarova M, Kandilarov I, et al. Anxiolytic effect of Satureja montana dry extract and its active compounds rosmarinic acid and carvacrol in acute stress experimental model. J Integr Neurosci 2022; 21:124. doi: 10.31083/j.jin2105124.
59. Naß J, Abdelfatah S, Efferth T. Ursolic acid enhances stress resistance, reduces ROS accumulation and prolongs life span in C. elegans serotonin-deficient mutants. Food Funct 2021; 12:2242-2256.
60. Kong CH, Park K, Kim DY, Kim JY, Kang WC, Jeon M, et al. Effects of oleanolic acid and ursolic acid on depression-like behaviors induced by maternal separation in mice. Eur J Pharmacol 2023; 956:175954.
61. Araki R, Sasaki K, Onda H, Nakamura S, Kassai M, Kaneko T, et al. Effects of cntinuous intake of rosemary extracts on mental health in working generation healthy Japanese men: Post-Hoc testing of a randomized controlled trial. Nutrients 2020; 12: 3551-3561.
62. Madadkar Dehkordi S, Noorian K. Comparing the effects of progressive muscle relaxation technique and aromatherapy with rosemary oil on preoperative anxiety in general surgery candidates. Complement Med J 2021; 11:116-127.
63. Achour M, Ben Salem I, Ferdousi F, Nouira M, Ben Fredj M, Mtiraoui A, et al. Rosemary tea consumption alters peripheral anxiety and depression biomarkers: A pilot study in limited healthy volunteers. J Am Nutr Assoc 2022; 41:240-249.
64. Can S, Yildirim Usta Y, Yildiz S, Tayfun K. The effect of lavender and rosemary aromatherapy application on cognitive functions, anxiety, and sleep quality in the elderly with diabetes. Explore 2024; 20:103033.
65. Sayadi Mank-Halati M, Rezaei M, Farzaei MH, Khatony A. Comparing the effects of rosemary aromatherapy and music therapy on anxiety levels in patients undergoing general surgery: A randomized controlled clinical trial. Explore 2024; 20:102976.
66. Ortega-Collazos E, Hinchado MD, Otero E, López-Jurado CF, Gálvez I, Legido JL, et al. Balneotherapy (mud-bath therapy) with a peloid enriched with rosmarinic acid enhances clinical outcomes and innate immune benefits in elderly patients with osteoarthritis: A pilot study. Appl Sci 2024; 14:12017-12030.
67. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review. Iran J Basic Med Sci 2024; 27:1492-1505.
68. Zeng J, Xie Z, Chen L, Peng X, Luan F, Hu J, et al. Rosmarinic acid alleviate CORT-induced depressive-like behavior by promoting neurogenesis and regulating BDNF/TrkB/PI3K signaling axis. Biomed Pharmacother 2024; 170:115994.
69. Bastos de Araújo D, Raiol de Almeida YN, Otake Hamoy MK, Vasconcelos de Souza L, Pacheco Hartcopff PF, Gonçalves dos Santos R, et al. Rosmarinus officinalis essential oil triggers depression followed by CNS excitability in Wistar rats. Front Nat Prod 2024; 3:1394657.
70. Wang XQ, Tang YH, Zeng GR, Wu LF, Zhou YJ, Cheng ZN, et al. Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-γ-dependent regulation of ADPN/FGF9 pathway. Psychopharmacology 2021; 238:501-516.
71. Azhar M, Zeng G, Ahmed A, Dar Farooq A, Choudhary MI, De-Jiang J, et al. Carnosic acid ameliorates depressive-like symptoms along with the modulation of FGF9 in the hippocampus of middle carotid artery occlusion-induced Sprague Dawley rats. Phytother Res 2021; 35:384-391.
72. Samy DM, Mostafa DK, Saleh SR, Hassaan PS, Zeitoun TM, Ammar GAG, et al. Carnosic acid mitigates depression-like behavior in ovariectomized mice via activation of Nrf2/HO-1 pathway. Mol Neurobiol 2023; 60:610-628.
73. Lataliza AAB, de Assis PM, da Rocha Laurindo L, Gonçalves ECD, Raposo NRB, Dutra RC. Antidepressant-like effect of rosmarinic acid during LPS-induced neuroinflammatory model: The potential role of cannabinoid receptors/PPAR-γ signaling pathway. Phytother Res 2021; 35:6974-6989.
74. Wang J, Wang S, Guo H, Li Y, Jiang Z, Gu T, et al. Rosmarinic acid protects rats against post-stroke depression after transient focal cerebral ischemic injury through enhancing anti-oxidant response. Brain Res 2021; 1757:147336.
75. Yu Y, Li Y, Qi K, Xu W, Wei Y. Rosmarinic acid relieves LPS-induced sickness and depressive-like behaviors in mice by activating the BDNF/Nrf2 signaling and autophagy pathway. Behav Brain Res 2022; 433:114006.
76. Verma H, Shivavedi N, Tej G, Kumar M, Nayak PK. Prophylactic administration of rosmarinic acid ameliorates depression-associated cardiac abnormalities in Wistar rats: Evidence of serotonergic, oxidative, and inflammatory pathways. J Biochem Mol Toxicol 2022; 36:e23160.
77. Verma H, Bhattacharjee A, Shivavedi N, Nayak PK. Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats. Naunyn Schmiedebergs Arch Pharmacol 2022; 395:1189-1207.
78. Colla ARS, Pazini FL, Lieberknecht V, Camargo A, Rodrigues ALS. Ursolic acid abrogates depressive-like behavior and hippocampal pro-apoptotic imbalance induced by chronic unpredictable stress. Metab Brain Dis 2021; 36:437-446.
79. Naß J, Abdelfatah S, Efferth T. The triterpenoid ursolic acid ameliorates stress in Caenorhabditis elegans by affecting the depression-associated genes skn-1 and prdx2. Phytomedicine 2021; 88:153598.
80. Ramos-Hryb AB, Pazini FL, Costa AP, Cunha MP, Kaster MP, Rodrigues ALS. Role of heme oxygenase-1 in the antidepressant-like effect of ursolic acid in the tail suspension test. J Pharm Pharmacol 2022; 74:13-21.
81. Hatami SM, Mehrpooya N, Vagharseyyedin SA, Rahimi H. Effect of aromatherapy with rosemary essential oil on occupational fatigue and depression experienced by ambulance technicians. Herb Med J 2020; 5:76-84.
82. Alvarado-García PAA, Soto-Vásquez MR, Rosales-Cerquin LE, Benites SM, Cubas-Romero TL, Jara-Aguilar DR, et al. Effect of Rosmarinus officinalis essential oil on anxiety, depression, and sleep quality. Pharmacogn J 2023; 15:343-349.
83. Zhang H, Huang R, Guo Q, Yang Z, Sun Y. Effects of natural extract rosmarinic acid on sleep quality and daily care in patients with depression. Sci Adv Mater 2023; 15:1486-1495.
84. Neuberger B, Mello FK, Mallmann MP, da Costa Sobral KG, Fighera MR, Royes LFF, et al. Beneficial effects of rosmarinic acid in vitro and in vivo models of epileptiform activity induced by pilocarpine. Brain Sci 2023; 13:289-299.
85. Lin T-K, Yeh K-C, Pai M-S, Hsieh P-W, Wang S-J. Ursolic acid inhibits the synaptic release of glutamate and prevents glutamate excitotoxicity in rats. Eur J Pharmacol 2024; 963:176280.
86. Juanjuan L, Huang Y, Wang Y, Zhang L, Qiang Y, Guo L, et al. Antiepileptic and neuroprotective mechanism of ursolic acid based on full-length transcriptome analysis. J China Pharm Univ 2024; 55:512-521.
87. Alrashdi J, Albasher G, Alanazi MM, Al-Qahtani WS, Alanezi AA, Alasmari F. Effects of Rosmarinus officinalis L. extract on neurobehavioral and neurobiological changes in male rats with pentylenetetrazol-induced epilepsy. Toxics 2023; 11:826-842.
88. Khamse S, Sadr SS, Roghani M, Rashvand M, Mohammadian M, Marefati N, et al. The effect of rosmarinic acid on apoptosis and nNOS immunoreactivity following intrahippocampal kainic acid injections in rats. Basic Clin Neurosci 2020; 11:41-48.
89. Liu KM, Huang Y, Wan PP, Lu YH, Zhou N, Li JJ, et al. Ursolic acid protects neurons in temporal lobe epilepsy and cognitive impairment by repressing inflammation and oxidation. Front Pharmacol 2022; 13:877898.
90. Sharma D, Walia S, Kaur S, Kapil L, Singh C, Singh A. Ursolic acid and caprylic acid cocktail approach against pentylenetetrazole-induced seizures-like behavior in adult zebrafish: Preclinical study. J Mol Neurosci 2025; 75:59. doi: 10.1007/s12031-024-02289-1.
91. Khera T, Rangasamy V. Cognition and pain: A review. Front Psychol 2021; 12: 673962.
92. Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Investigating the ameliorative effect of alpha-mangostin on development and existing pain in a rat model of neuropathic pain. Phytother Res 2020; 34:3211-3225.
93. Borgonetti V, Galeotti N. Rosmarinic acid reduces microglia senescence: A novel therapeutic approach for the management of neuropathic pain symptoms. Biomedicines 2022; 10: 1468-1480.
94. Déciga-Campos M, Beltrán-Villalobos KL, Aguilar-Mariscal H, González-Trujano ME, Ángeles-López GE, Ventura-Martínez R. Synergistic herb-herb Interaction of the antinociceptive and anti-inflammatory effects of syzygium aromaticum and Rosmarinus officinalis combination. Evid Based Complement Alternat Med 2021; 2021:8916618.
95. Hajhashemi V, Salimian M, Hajihashemi O. Involvement of the NO/cGMP/K ATP pathway in the antinociceptive effect of rosemary (Rosmarinus officinalis) essential oil in mice. Behav Pharmacol 2023; 34:37-44.
96. Shrivastava S, Bahuguna T, Mondal S, Kumar S, Mathew B, Jeengar MK, et al. Attenuation of adjuvant-induced arthritis with carnosic acid by inhibiting mPGES-1, COX-2, and bone loss in male SD rats. Immunopharmacol Immunotoxicol 2024; 46:538-549.
97. Wei T, Liu Y, Li M. Anti-inflammatory and anti-arthritic activity of rosmarinic acid isolated from Rosmarinus officinalis in an experimental model of arthritis. Indian J Pharm Educ Res 2021; 55:507-516.
98. Moradi M, Mashhadi Akbar Boojar M, Saberi M, Rahimi Salkuyeh H, Ghorbani M, Amanpour H, et al. Comparison of analgesic effect of rosmarinic acid with piroxicam in mice. Int J Basic Sci Med 2022; 7:28-33.
99. Karakus AA, Dallali I, Arslan R, Eken H, Hasan A, Bektas N. Examination of the antiallodynic effect of rosmarinic acid in neuropathic pain and possible mechanisms of action. Neurosci Lett 2024; 842:137994.
100. Rong ZJ, Chen M, Cai HH, Liu GH, Chen JB, Wang H, et al. Ursolic acid molecules dock MAPK1 to modulate gut microbiota diversity to reduce neuropathic pain. Neuropharmacology 2024; 252:109939.
101. Tahoonian Golkhatmi F, Abedian Z, Emami SA, Esmaily H. Comparing the effect of rosemary and mefenamic acid capsules on symptoms of primary dysmenorrhea: A randomized double-blind trial. J Mazandaran Univ Med Sci 2020; 30:40-52.
102. Heydari Z, Ansari Jaberi A, Seyed Bagheri SH, Negahban Bonabi T. Effects of rosemary oil on osteoarthritis symptoms in the elderly: A double-blind randomized control. J Occup Health Epidemiol 2022; 11:171-179.
103. Mohammadzadeh L, Ghasemzadeh Rahbardar M, Razavi BM, Hosseinzadeh H. Crocin protects malathion-induced striatal biochemical deficits by inhibiting apoptosis and increasing α-synuclein in rats’ striatum. J Mol Neurosci 2022; 72:983-993.
104. Lin CY, Chen WJ, Fu RH, Tsai CW. Upregulation of OPA1 by carnosic acid is mediated through induction of IKKγ ubiquitination by parkin and protects against neurotoxicity. Food Chem Toxicol 2020; 136:110942.
105. Lin CY, Huang YN, Fu RH, Liao YH, Kuo TY, Tsai CW. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of neuroprotection by carnosic acid. Phytomedicine 2021; 80:153369.
106. Lin CY, Huang YC, Wu CR, Wu HT, Fu RH, Tsai CW. Carnosic acid attenuated cytochrome c release through the mitochondrial structural protein Mic60 by PINK1 in SH-SY5Y cells. Food Chem Toxicol 2023; 173:113636.
107. Han X, Han B, Zhao Y, Li G, Wang T, He J, et al. Rosmarinic acid attenuates rotenone-induced neurotoxicity in SH-SY5Y Parkinson’s disease cell model through Abl inhibition. Nutrients 2022; 14: 3508-3522.
108. Cai G, Lin F, Wu D, Lin C, Chen H, Wei Y, et al. Rosmarinic acid inhibits mitochondrial damage by alleviating unfolded protein response. Front Pharmacol 2022; 13:859978.
109. Sun A, Li Y-f, Miao Y, Wang H-x, Zhang L-l. Research on the mechanism of ursolic acid for treating Parkinson’s disease by network pharmacology and experimental verification. Heliyon 2024; 10:e34113.
110. Gao J, Lei B, He H, Xi D, Wang X, Lian C, et al. Ursolic acid inhibits autophagy-dependent neuronal cell death by reducing oxidative stress levels in an in vitro model of Parkinson’s disease. Mol Cell Toxicol 2024; 20:1067-1082.
111. Imani N, Modaresi M. Comparative effect of rosemary hydroalcoholic extract and selegiline on Parkinson’s behavioral symptoms. J Altern Vet Med 2020; 3:377-388.
112. Rad SNH, Kashani MHG, Abrari K. Pre-treatment by rosemary extract or cell transplantation improves memory deficits of Parkinson’s disease: When tradition meets the future. Braz Arch Biol Technol 2021; 64:e21180392.
113. Amani M, Hosseininia A, Sheikhkanloui Milan H. The effect of aqueous extract of rosemary (Rosmarinus officinalis) on Parkinson’s disease Induced by MPTP in male mice. J Ardabil Univ Med Sci 2023; 23:26-37.
114. Kousha A, Vaezi G, Kashani MHG, Hojati V. Simultaneous treatment with cells and rosemary extract ameliorates 6-OHDA-induced toxicity in the hippocampus of mice. J Adv Pharm Technol Res 2024; 15:117-124.
115. Zhao Y, Han Y, Wang Z, Chen T, Qian H, He J, et al. Rosmarinic acid protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in zebrafish embryos. Toxicol In Vitro 2020; 65:104823.
116. Lv R, Du L, Zhou F, Yuan X, Liu X, Zhang L. Rosmarinic acid alleviates inflammation, apoptosis, and oxidative stress through regulating miR-155-5p in a mice model of Parkinson’s disease. ACS Chem Neurosci 2020; 11:3259-3266.
117. Presti-Silva SM, Herlinger AL, Martins-Silva C, Pires RGW. Biochemical and behavioral effects of rosmarinic acid treatment in an animal model of Parkinson’s disease induced by MPTP. Behav Brain Res 2023; 440:114257.
118. Presti-Silva SM, Rodrigues-Ribeiro L, Gorshkov V, Kjeldsen F, Verano-Braga T, Pires RGW. Proteomic analysis of substantia nigra reveals molecular insights into the neuroprotection effect of rosmarinic acid treatment in MPTP-induced mouse model of Parkinson’s disease. Proteomics Clin Appl 2025:e70006.
119. Zahra W, Rai SN, Birla H, Singh SS, Rathore AS, Dilnashin H, et al. Neuroprotection of rotenone-induced Parkinsonism by ursolic acid in PD mouse model. CNS Neurol Disord Drug Targets 2020; 19:527-540.
120. Peshattiwar V, Muke S, Kaikini A, Bagle S, Dighe V, Sathaye S. Mechanistic evaluation of ursolic acid against rotenone induced Parkinson’s disease- emphasizing the role of mitochondrial biogenesis. Brain Res Bull 2020; 160:150-161.
121. Zahra W, Birla H, Singh SS, Rathore AS, Dilnashin H, Singh R, et al. Anti-Parkinsonian effect of Mucuna pruriens and Ursolic acid on GSK3β/Calcium signaling in neuroprotection against rotenone-induced Parkinsonism. Phytomed Plus 2022; 2:100343.
122. Kandiş S, Altıntaş L, Kızıldağ S, Simsek F, Ateş M, Alaçam H, et al. Comparison anti-oxidant and neuroprotective effects of extra-virgin olive oil, donepezil and rosmarinic acid on aluminum chloride-induced Alzheimer’s in rat models. Ankara Univ Vet Fak Derg 2022; 69:171-181.
123. Mehdinavaz Aghdam A, Fakhari S. The results of progressive muscle relaxation and aromatherapy with rosemary oil on preoperative anxiety in general surgery candidates. Int J New Chem 2022; 9:28-36.
124. Azizi S, Mohamadi N, Sharififar F, Dehghannoudeh G, Jahanbakhsh F, Dabaghzadeh F. Rosemary as an adjunctive treatment in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Complement Ther Clin Pract 2022; 49:101685.
125. Flores N, Rivillas-Acevedo L, Caballero J, Melo F, Caballero L, Areche C, et al. Rosmarinic acid turned α-syn oligomers into non-toxic species preserving microtubules in Raw 264.7 cells. Bioorg Chem 2024; 151:107669.
126. Bang Y, Kwon Y, Kim M, Moon SH, Jung K, Choi HJ. Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson’s disease mice model. Acta Pharmacol Sin 2023; 44:752-765.
127. Nass J, Efferth T. Ursolic acid ameliorates stress and reactive oxygen species in C. elegans knockout mutants by the dopamine Dop1 and Dop3 receptors. Phytomedicine 2021; 81:153439.
)